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Summary 
Objectives: To investigate the risk of pregnancy complications in women with and without 
polycystic ovary syndrome after consideration of lifestyle factors. 
Design: Prospective cohort  
Patients and measurements: Participants (n=5628) were apparently healthy nulliparous 
women with singleton pregnancies from the Screening for Pregnancy Endpoints study in New 
Zealand, Australia, United Kingdom and Ireland. Multivariable regression models were 
performed assessing the association of self-reported polycystic ovary syndrome status with 
pregnancy complications with consideration of lifestyle factors at the 15th week of gestation. 
Results: Women with polycystic ovary syndrome (n=354) were older, had a higher 
socioeconomic index and body mass index and were less likely to consume alcohol and 
smoke but more likely to do vigorous exercise and take multivitamins. In univariable analysis 
polycystic ovary syndrome was associated with increased risk of gestational diabetes [OR: 
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4.0]. In multivariable models, polycystic ovary syndrome was only significantly associated 
with decreased risk of large for gestational age [OR: 0.62, 95% CI: 0.40, 0.98] with a 
population attributable risk of 0.22%. None of the other outcomes were attributable to 
polycystic ovary syndrome status. 
Conclusions: Polycystic ovary syndrome is associated with a lower risk of large for 
gestational age infants. In this low risk population, the risk of pregnancy complications was 
not increased in women with polycystic ovary syndrome who were following a healthy 
lifestyle. Further studies are warranted assessing the contribution of lifestyle factors to the 
risk of pregnancy complications in higher risk groups of women with and without polycystic 
ovary syndrome. 
 
Key words: Birth weight, Large for gestational age, Preterm birth, Gestational diabetes, 
Gestational hypertension, Lifestyle, Polycystic ovary syndrome 
 
Introduction 
Polycystic ovary syndrome (PCOS) affects 8-18% of reproductive-aged women.1 
According to the Rotterdam criteria, PCOS compromises at least two of the three features: 
menstrual irregularity, hyperandrogenism, and polycystic ovaries.2 PCOS is associated with 
reproductive, metabolic and psychological dysfunction.3 Insulin resistance (IR) is a key 
etiological feature in PCOS4 which amplifies both ovarian dysfunction5 and metabolic 
disturbances.6 Obesity and a tendency to central obesity are also common among women with 
PCOS and can worsen the associated disorders.7, 8  Pregnant women with PCOS are at an 
increased risk for pregnancy and birth complications such as gestational diabetes (GDM), 
gestational hypertension (GH), pre-eclampsia (PE), preterm birth, caesarean section and 
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In the general population, multiple risk factors including advanced maternal age,10 
certain ethnicities,11 obesity and excessive gestational weight gain (GWG),12 low 
socioeconomic status,13 parity, multiple pregnancy,14 pre-existing medical conditions10 and 
high risk behaviors such as smoking and alcohol consumption,11 vitamin or nutrient 
deficiencies15 and low physical activity 16 increase the risk for pregnancy complications. 
Comparatively, a healthy lifestyle reduces the risk.17-19 However, it is not known if the higher 
risk of pregnancy complications in PCOS is related to PCOS status per se or whether it is an 
indirect effect of a higher risk profile; and there may be both modifiable and non-modifiable 
risk factors associated with pregnancy complications in PCOS. 
In the limited research examining the risk profile of women with PCOS relating to 
adverse pregnancy consequences, obesity, excessive GWG, pre-pregnancy IR and multiple 
pregnancies are reported in PCOS.20 Alternatively, the pathophysiology of PCOS may 
contribute to pregnancy complications. Insulin sensitivity decreases over the course of a 
normal pregnancy. This, in conjunction with pre-existing IR, may further increase the risk of 
pregnancy complications in PCOS.21, 22 The cause of infertility and higher rate of multiple 
pregnancies following fertility treatment may also contribute to pregnancy complications.14, 21  
Given the short and long term health and economic burden of pregnancy 
complications for both mothers and infants,23 the assessment of modifiable factors for 
primary prevention of pregnancy complications is crucial. There are research gaps regarding 
the relative contribution of lifestyle and non-lifestyle related factors to pregnancy 
complications in PCOS as a specific high risk group for pregnancy complications. Therefore, 
the aim of this study is to identify the risk of pregnancy complications among women with 
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Materials and methods 
Study design 
This was a prospective cohort study of pregnant participants of the Screening for 
Pregnancy Endpoints (SCOPE) study.24, 25 SCOPE is a multi-center prospective cohort study 
of low-risk, nulliparous women with singleton gestations from Auckland (New Zealand), 
Adelaide (Australia), Manchester, Kings, Leeds (United Kingdom) and Cork (Ireland), with 
the primary aim of developing screening tests for prediction of PE, spontaneous preterm birth 
(SPTB) and small for gestational age (SGA) babies. Women were invited for participation 
prior to 15±1 weeks’ gestation and recruited between November 2004 and February 2011. 
Pregnancies at high risk for development of PE, SPTB and SGA were excluded. Each local 
ethics committee approved the study protocol [New Zealand AKX/02/00/364, Australia REC 
1712/5/2008, London and Manchester 06/MRE01/98 and Cork ECM5 (10)05/02/08], and all 
patients provided signed informed consent prior to participation.  
 
Participants 
All SCOPE women who met the inclusion criteria of the study (n=5628) were 
considered. Interview, physical examination and blood and urine sampling were performed 
for all participants at 15±1 weeks’ gestation. Comprehensive clinical data were collected 
which included demographic and socio-economic information, past medical, obstetric and 
gynecological history and family history of any obstetric and medical disorders. Ongoing 
pregnancy data including dietary information, low-dose multivitamin supplementation, 
smoking, alcohol consumption and exercise activity were collected for all participants. 
Women were followed up until delivery for pregnancy outcomes and newborn measurements. 
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Exposures 
PCOS was defined as a self-report diagnosis including confirmatory self-report 
information about PCOS diagnosis through ultrasound and/or blood test. Self-reported 
diagnosis of PCOS has been validated in genetic studies to be similar to medically diagnosed 
PCOS.26  Women were also asked whether they had received infertility treatment to conceive 
their current pregnancy and whether women with PCOS continued metformin throughout the 
first trimester. A socio-economic index (SEI) was defined based on the New Zealand SEI.27 
BMI was calculated using measured weight (kg) divided by measured height squared (m2). 
Alcohol consumption and smoking were each considered as a binary variables based on 
drinking any amount of alcohol or smoking any number of cigarettes at the 15±1 weeks’ visit. 
Multivitamin intake was assessed as frequency of intake (daily, less than daily and no intake). 
The number of times a woman engaged in physical activity per week in the last month was 
categorized as: vigorous exercise (resulting in heavy breathing or being out of breath) and 
moderate exercise (intensity level was not enough to result in heavy breathing or being out of 
breath).28 Fruit and leafy vegetable intake were defined as frequencies consumed per day in 
the last month prior to the visit. 
 
Outcomes 
Gestational diabetes mellitus was defined using the new World Health Organization 
classification (fasting glucose of ≥5.1 mmol/L or following an Oral Glucose Tolerance Test, a 2 h 
level of ≥8.5 mmol/L) 29. Universal screening was not employed for GDM in Ireland and the UK; 
women were only screened if they were identified as being at risk based on factors such as family 
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The type of prescribed treatment in women with GDM was documented. GH was defined as 
systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg after the 
20th week of pregnancy on at least two assessments 4-hours apart.30 Preeclampsia was defined 
as systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or both, on at least two occasions four hours 
apart after 20 weeks’ gestation but before the onset of labour, or postpartum, with either proteinuria 
(24 hour urinary protein ≥300 mg or spot urine protein: creatinine ratio ≥30 mg/mmol creatinine or 
urine dipstick protein ≥++) or any multisystem complication of PE. 31-33 Spontaneous preterm birth 
was defined as spontaneous delivery before 37+0 weeks’ gestation. Small- and large- for gestational 
age were defined as a birth weight <10th or >90th customized centile, respectively. Early GWG was 




All statistical procedures were performed using Stata version 14 (StataCorp, 14 
College Station, Texas, USA). All reported P values were 2-tailed, and a P value <0.05 was 
considered to be statistically significant for all analyses. Continuous outcomes were presented 
as mean ± standard deviation (SD) or median (first and third quartiles) and categorical 
outcomes were presented as frequency (proportions). Baseline comparisons between women 
with and without PCOS were analyzed by unpaired t-test or Mann-Whitney as appropriate for 
continuous data and chi-squared test for categorical data. Logistic regression models were 
used to estimate the odds ratio (OR) of development of each categorical pregnancy outcome 
as the dependent variable and PCOS status as an independent variable on unadjusted models 
and then on adjusted models with the additional independent variables of SCOPE recruitment 
center, infertility treatment, age, ethnicity (Caucasian vs. non-Caucasian), SEI, BMI, alcohol 
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and fruit and leafy vegetable intake. The same strategies were applied to linear regression 
models for continuous pregnancy outcomes (infant birth weight and early GWG). Additional 
independent variables included in individual adjusted analysis were family history of relevant 
complication (family history of GDM for GDM; family history of GH, PE or hypertension 
for GH and PE, and family history of SPTB for SPTB), infant sex (birth weight, SGA and 
LGA) and gestational age at week of measurement (birth weight, SGA and LGA). Models 
were constructed to avoid collinearity and assessed for standard assumptions. Regression 
models were constructed based on univariate associations between dependent and 
independent variables or on hypothesis testing. The proportion of each outcome in the 
population attributable to PCOS was calculated as [Population attributable risk (PAR)= b(RR 




 Of the 5628 pregnant SCOPE women, 354 (6.3%) women had PCOS. The baseline 
and lifestyle characteristics of participants by PCOS status are presented in Tables 1 and 2. 
Compared to women without PCOS, women with PCOS were older and had a higher weight, 
BMI and SEI. They were less likely to be smoking or drinking alcohol but more likely to be 
taking multivitamins, exercising vigorously and frequently, earning a higher income, be more 
educated, to have a professional occupation and to have received infertility treatment for their 
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Of the 2078 screened women for GDM, the crude prevalence was higher among 
women with PCOS compared to non PCOS women [9.7 vs. 4.7%; OR: 2.2 95% CI 1.2, 4.0]. 
Of these, only 4 women without PCOS received metformin either alone or in combination 
with insulin after GDM diagnosis. The proportion of GH [7.3 vs. 8.4%; OR: 0.86 95% CI 
0.57, 1.3] and PE (5.9 vs. 6.7%; OR: 0.88 95% CI 0.56, 1.4] and mean difference of early 
GWG [2.3±2.2 kg vs. 2.5±2.0 kg; OR: -0.22 95% CI -0.44, 0.004] were similar among 
women with PCOS compared to those without PCOS. On crude models, there were no 
differences in infant birth weight [3388.3±603.3 g vs. 3401.7±590.8 g; OR: -13.4 95% CI: -
77.1, 50.2], prevalence of SGA [10.2 vs. 11.4%; OR: 0.88 95% CI: 0.62, 1.3], LGA [6.5 vs. 
9.7%; OR: 0.65 95% CI: 0.42, 1.00] or SPTB [5.7 vs. 4.1%; OR: 1.4 95% CI: 0.87, 2.2] in 
infants born to mothers with PCOS compared to without PCOS.  
In the multivariable models, early GWG [OR: -0.12 kg 95% CI: -0.35, 0.10] and 
infant birth weight [OR: 21.20 g 95% CI: -24.7, 67.10] were similar in women with and 
without PCOS. Figure 1 shows the association between PCOS and maternal and infant 
outcomes, after adjusting for a range of lifestyle exposures. There was no longer any 
association between PCOS status and any maternal or infant outcomes except for LGA [OR: 
0.62 95% CI: 0.40, 0.98]. There was a lower proportion of LGA babies attributable to PCOS 
(0.22%, P=0.015) after adjustment for lifestyle and non-lifestyle factors. 
 
Discussion 
In this large prospective cohort study of pregnant women, PCOS was only 
significantly associated with a decreased risk of LGA babies after adjustment for lifestyle and 
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this was no longer maintained in the adjusted analyses. There were no significant associations 
between PCOS and other maternal or infant outcomes.  
In the current study, pregnant women with PCOS were demonstrated to be following 
a healthier lifestyle with a lower rate of smoking and lower alcohol consumption but a higher 
proportion taking multivitamins and engaging in more frequent vigorous exercise. This is 
consistent with prior reports of women with PCOS having a greater risk perception for future 
lifestyle-related diseases such as obesity and diabetes34 and a greater tendency to be 
following healthy lifestyle behaviors for weight management35 compared to women without 
PCOS. This is possibly related to lifestyle advice being recommended as first-line treatment 
for PCOS in evidence-based guidelines.36 Given their greater likelihood of being overweight 
or obese and having received infertility treatment for their current pregnancy, the women 
with PCOS in this study may also have received additional lifestyle management advice for 
these respective conditions.37 We also found that women with PCOS were older in 
comparison to women without PCOS. Older women typically prepare themselves better for 
pregnancy through seeking information, following healthy lifestyle behaviors and managing 
their weight.10 Similarly, women with PCOS had a higher SEI, income, educational and 
occupation level. These are considered surrogates for health status and healthy lifestyle 
behaviors; low SEI is associated with an increased risk of pregnancy complications.13  
We demonstrate a 38% lower risk of LGA among women with PCOS after 
adjustment for lifestyle and non-lifestyle factors. Prior studies report an increased risk of 
adverse obstetric outcomes and also increased risk of metabolic complications in LGA babies 
later in life.38, 39 While some prior studies have reported that PCOS is associated with a higher 
rate of LGA babies,40-42 this was not supported by recent meta-analyses.23, 43, 44 In the general 
population several factors including obesity, excessive GWG, diabetes mellitus, GDM, 
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45 As overweight and obesity and diabetes mellitus are elevated in PCOS 7, 46 and the older 
age of women with PCOS, it may be expected that PCOS would be associated with a greater 
prevalence of LGA babies.47 The reason for these disparate findings is unclear but may be 
related to the overall healthier profile in women with PCOS. The design of the SCOPE study 
accounted for the confounding effects of factors such as parity, pre-existing diabetes mellitus 
and ethnicity on LGA babies.25 Additional factors such as GWG are also strongly predictive 
for LGA babies.48, 49 Women with PCOS have generally higher longitudinal weight gain 
compared to women without PCOS 50 which could be expected to contribute to greater GWG. 
However, while BMI was higher at 15 weeks of gestation for women with PCOS, we 
observed similar early GWG for women with and without PCOS. As early GWG is a 
surrogate for total GWG,51 this indicates that total GWG was likely similar between the two 
groups. This again highlights the lack of additional risk factors for pregnancy complications 
in women with PCOS in this low risk cohort. 
We also found that women with and without PCOS had a similar risk for GDM, GH, 
PE, SGA and SPTB after consideration of lifestyle and non-lifestyle factors. This finding is in 
contrast to prior meta-analyses where PCOS was associated with increased risk of GDM, GH, 
PE and PTB although the relationship of PCOS with an increased risk of SGA is less 
consistently reported.9, 23, 44 The reason for our discrepant findings is unclear but may be 
related to the SCOPE design with the inclusion of low risk women. Aging has been 
previously reported to be associated with worsened pregnancy outcomes.10 However, only a 
small proportion of women with and without PCOS (15.8 vs. 12.5% respectively) were over 
35 years as a previously characterized age threshold for increased pregnancy complications.10 
Given the role of IR and obesity in the pathophysiology of PCOS, women with PCOS are 
considered to be potentially at higher risk of GDM.23 Excessive GWG, particularly early 
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normal pregnancy induced IR in the second half of gestation.52 Excessive GWG and diabetes 
in pregnancy, either pre-existing or new onset, are also independently associated with 
increased risk of miscarriage, GH, PE, SPTB, perinatal mortality, congenital malformation, 
macrosomia and caesarean section.52, 53 The lack of an increased risk of pregnancy 
complications in the present study may therefore again be related to the similar early GWG 
and GDM and greater healthy lifestyle behaviors in women with PCOS. This is consistent 
with a study on 7985 nulliparous women which reported early GWG was a predictor for 
excessive total GWG, GDM, LGA birth and macrosomia.51 This highlights that optimizing 
lifestyle prior to or early in pregnancy may be effective in reducing the risk of pregnancy 
complications.51 This is in keeping with prior meta-analyses that reported antenatal diet 
and/or exercise interventions resulted in lower GWG54-56 and GDM.55  
This study has several strengths and limitations. A key strength was the prospective 
cohort design of the SCOPE study with repeated follow-ups over pregnancy. This minimizes 
recall bias with regards to pregnancy complications. The multi-center data collection and 
large sample size increase the generalizability of the results across a number of countries with 
regards to different demographic characteristics such as age, ethnicity, SEI and BMI and 
different lifestyles in terms of smoking and alcohol consumption.57 Self-reported PCOS 
diagnosis was strengthened through collection of supporting self-report information on the 
use of blood tests or ultrasound to confirm diagnosis. While the use of more comprehensive 
assessments of dietary intake would have strengthened the study further, the use of single 
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In conclusion, in this population of low-risk, nulliparous women with PCOS did not 
have a higher risk of adverse maternal and infant pregnancy complications in comparison to 
women without PCOS and instead had a lower risk of LGA births. They also had a more 
favorable lifestyle profile compared to women without PCOS. These findings highlight that 
following a healthy lifestyle may compensate for the risk of having PCOS for pregnancy 
complications. Thus risk estimation for pregnancy outcomes could be similarly performed in 
women with and without PCOS providing they have a similar health or lifestyle profile. 
These findings suggest that the beneficial effects of lifestyle modification on PCOS, as 
recommended by evidence-based PCOS guidelines,36 may extend to improved pregnancy 
outcomes. However, this needs to be confirmed by assessing both healthy and at risk groups 
for pregnancy complications in women with well-defined PCOS and controls and with 
consideration of lifestyle factors.  
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